GW6471 ≥98% (durch HPLC), Sigma-Aldrich®

Lieferant: Merck

Synonyme: (S,Z)-N-(3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-((4-oxo-4-(4-(trifluoromethyl)phenyl)but-2-en-2-yl)amino)propyl)propionamide, N-((2S)-2-(((1Z)-1-Methyl-3-oxo-3-(4-(trifluoromethyl)phenyl)prop-1-enyl)amino)-3-(4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)phenyl)propyl)propanamide

M-Clarity™ Qualitätsstufe = MQ100

G5045-5MG
SIALG5045-5MGEA 309 EUR
SIALG5045-5MG
GW6471 ≥98% (durch HPLC), Sigma-Aldrich®
GW6471

GW6471 prevents apoptosis and cell cycle arrest at G0/G1 in renal cell carcinoma. It reduces enhanced fatty acid oxidation and oxidative phosphorylation associated with glycolysis inhibition.


GW6471 has been used:
to investigate the role of peroxisome proliferator-activated receptors (PPARs) alpha in perfluorooctanoic acid (PFOA) induced developmental cardiotoxicity
to abolish the protection of bezafibrate (BZA) against hypertrophy
to block the enhanced activity of the hepatitis B virus (HBV) core promoter

Formel: C₃₅H₃₆F₃N₃O₄
Molecular Weight: 619,67 g/mol
Lagertemperatur: Kühlschrank
MDL: MFCD07784503
CAS-Nummer: 880635-03-0

Bestellen

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR